MicraTM VR2 leadless pacemaker
for bradyarrhythmia management
Micra™ VR2 is a single-chamber leadless pacemaker that provides an unmatched leadless pacing experience for bradycardia patients.
Overview
Micra™ VR2 is a single-chamber leadless pacemaker used to treat patients with bradycardia. This device is delivered percutaneously via a minimally invasive approach and does not require the use of leads.
Micra™ VR2 devices are implanted with the same streamlined procedure as previous Micra™ devices.
Micra™ VR2 features
Increased battery longevity
The projected median longevity is nearly 17 years, which means more than 80% of patients only need one Micra™ device for life.1
Enhanced delivery system
The updated delivery system now has a rounded catheter tip with more surface area to decrease tip pressure during device implant.2
Model specifications
| Parameter |
Micra VR2 |
|---|---|
| Pacing mode |
VVI, VVIR, VOO, OVO, OFF |
| Mass |
1.75 g |
| Volume |
0.8 cc |
| Electrode spacing |
18 mm |
| Battery longevity |
16.7 years1 |
| Accelerometer-based mechanical atrial sensing |
N/A |
| Accelerometer-based rate response |
Yes |
| MRI SureScan™ |
≤ 3T |
| CareLink™ remote monitoring |
Yes |
Micra™ clinical evidence
Educational resources on Medtronic Academy
Access interactive courses, videos, and educational resources to extend your knowledge on Micra™.
Request more information
References
1
Sheldon T, Escalante K, Fagan D. Device Longevity and AV Synchrony Algorithm Modeling of a Leadless Pacemaker Family: A Virtual Patient Analysis. January 2023. Medtronic data on file.
2
Roberts PR et al, Preclinical cardiac perforation reduction in leadless pacing: An update to the Micra leadless pacemaker delivery system. Pacing Clin Electrophysiol. 2023 Sep;46(9):1085-1091.
3
Williams E, Whiting J. Micra Transcatheter Pacing System Size Comparison. November 2014. Medtronic data on file.
4
Nippoldt D, Whiting J. Micra Transcatheter Pacing System Device Volume Characterization Comparison. November 2014. Medtronic data on file.
